[Conflict of interest].

Q4 Medicine

Medizinische Monatsschrift fur Pharmazeuten Pub Date : 2021-08-01 DOI:10.1093/ajhp/50.11.2398

S. Heinzl

{"title":"[Conflict of interest].","authors":"S. Heinzl","doi":"10.1093/ajhp/50.11.2398","DOIUrl":null,"url":null,"abstract":"1 D€onmez MI, Selvi I, Oktar T. Re: Vesicoureteral reflux treatment following kidney transplantation potentially prevents graft function deterioration and allows long-term graft survival. Int J Urol. 2022; doi: 10.1111/iju.14972. 2 Hirose T, Hotta K, Harada H, Tanabe T, Sasaki H, Shinohara N. Vesicoureteral reflux treatment following kidney transplantation potentially prevents graft function deterioration and allows long-term graft survival. Int J Urol. 2022;29(7):699–706. 3 Hotta K, Miura M, Wada Y, Fukuzawa N, Iwami D, Sasaki H, et al. Atrophic bladder in long-term dialysis patients increases the risk for urological complications after kidney transplantation. Int J Urol. 2017;24(4):314–9. 4 Inoue T, Satoh S, Obara T, Saito M, Numakura K, Narita S, et al. Cystometric evaluation of recovery in hypocompliant defunctionalized bladder as a result of long-term dialysis after kidney transplantation. Int J Urol. 2016;23(8):694– 700. 5 Tadrist A, Morelli M, Gondran-Tellier B, Akiki A, McManus R, Delaporte V, et al. Long-term results of endoscopic treatment in vesicoureteral reflux after kidney transplantation. World J Urol. 2022;40(3):815–21.","PeriodicalId":18540,"journal":{"name":"Medizinische Monatsschrift fur Pharmazeuten","volume":"21 2 1","pages":"29"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ajhp/50.11.2398","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medizinische Monatsschrift fur Pharmazeuten","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ajhp/50.11.2398","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

1 D€onmez MI, Selvi I, Oktar T. Re: Vesicoureteral reflux treatment following kidney transplantation potentially prevents graft function deterioration and allows long-term graft survival. Int J Urol. 2022; doi: 10.1111/iju.14972. 2 Hirose T, Hotta K, Harada H, Tanabe T, Sasaki H, Shinohara N. Vesicoureteral reflux treatment following kidney transplantation potentially prevents graft function deterioration and allows long-term graft survival. Int J Urol. 2022;29(7):699–706. 3 Hotta K, Miura M, Wada Y, Fukuzawa N, Iwami D, Sasaki H, et al. Atrophic bladder in long-term dialysis patients increases the risk for urological complications after kidney transplantation. Int J Urol. 2017;24(4):314–9. 4 Inoue T, Satoh S, Obara T, Saito M, Numakura K, Narita S, et al. Cystometric evaluation of recovery in hypocompliant defunctionalized bladder as a result of long-term dialysis after kidney transplantation. Int J Urol. 2016;23(8):694– 700. 5 Tadrist A, Morelli M, Gondran-Tellier B, Akiki A, McManus R, Delaporte V, et al. Long-term results of endoscopic treatment in vesicoureteral reflux after kidney transplantation. World J Urol. 2022;40(3):815–21.

查看原文本刊更多论文

[利益冲突]。

1 D€onmez MI，Selvi I，Oktar T.Re:肾移植后膀胱输尿管反流治疗可能防止移植物功能恶化，并允许移植物长期存活。国际泌尿外科杂志。2022年；doi:10.1111/iju.14972。2 Hirose T、Hotta K、Harada H、Tanabe T、Sasaki H、Shinohara N.肾移植后膀胱输尿管反流治疗可能防止移植物功能恶化，并允许移植物长期存活。国际泌尿外科杂志。2022年；29（7）：699–706.3 Hotta K，Miura M，Wada Y，Fukuzawa N，Iwami D，Sasaki H等。长期透析患者的萎缩性膀胱增加了肾移植后泌尿系统并发症的风险。国际泌尿外科杂志。2017年；24（4）：314–9.4 Inoue T，Satoh S，Obara T，Saito M，Numakura K，Narita S等。肾移植后长期透析导致低依从性功能失调膀胱恢复的囊性评估。国际泌尿外科杂志。2016年；23（8）：694–700。5 Tadrist A，Morelli M，Gondran Tellier B，Akiki A，McManus R，Delaporte V等。肾移植后膀胱输尿管反流内镜治疗的长期结果。世界泌尿外科杂志。2022年；40（3）:815–21。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medizinische Monatsschrift fur Pharmazeuten Medicine-Pharmacology (medical)

CiteScore

0.10

自引率

0.00%

发文量

期刊介绍： •Übersichtsbeiträge zum Beispiel zur Anatomie, Physiologie und Pathophysiologie, zur Pharmakologie einer Substanz- oder Indikationsgruppe, zur Behandlung eines Krankheitsbilds •Fallberichte: der klinisch-pharmazeutische Fall •Pharmakologie aktuell: Neue Therapieprinzipien, neue Wirkungsmechanismen, neue Substanzen werden kurz und verständlich vorgestellt •Ernährungsforum: Fundierte Informationen zur Ernährung und zu Diätformen •Fragen aus der Praxis: Experten beantworten Leseranfragen •Editorial: Kommentare zu pharmazeutischen Themen •Nachrichten aus der medizinischen Forschung mit Neuigkeiten zu Diagnostik und Therapie